Dr. Tsumura is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2279 45th St
Sacramento, CA 95817Phone+1 916-734-5959
Education & Training
University of California Davis HealthFellowship, Hematology and Medical Oncology, 2022 - 2025
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 2019 - 2022
Loyola University Chicago Stritch School of MedicineClass of 2019
Certifications & Licensure
CA State Medical License 2022 - 2026
OR State Medical License 2021 - 2023- American Board of Internal Medicine Internal Medicine
Awards, Honors, & Recognition
- AOA Alpha Omega Alpha, 2019
Publications & Presentations
PubMed
- 25 citationsAcyl protein thioesterase 1 and 2 (APT-1, APT-2) inhibitors palmostatin B, ML348 and ML349 have different effects on NRAS mutant melanoma cells.Igor Vujic, Martina Sanlorenzo, Rosaura Esteve-Puig, Marin Vujic, Andrew Kwong
Oncotarget. 2016-01-13 - 2 citationsCheckpoint inhibition in hematologic malignancies.Aaron Tsumura, Daniel Levis, Joseph M Tuscano
Frontiers in Oncology. 2023-01-01 - 56 citationsMetformin and trametinib have synergistic effects on cell viability and tumor growth in NRAS mutant cancerIgor Vujic, Martina Sanlorenzo, Christian Posch, Rosaura Esteve-Puig, Adam J. Yen
Oncotarget. 2015-01-20
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
